{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:36:20Z","timestamp":1787960180874,"version":"build-2784847793"},"reference-count":152,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81602945"],"award-info":[{"award-number":["81602945"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673283"],"award-info":[{"award-number":["81673283"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002338","name":"Ministry of Education","doi-asserted-by":"publisher","award":["IRT_15R27"],"award-info":[{"award-number":["IRT_15R27"]}],"id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["lzujbky-2017-k11"],"award-info":[{"award-number":["lzujbky-2017-k11"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["lzujbky-2018-87"],"award-info":[{"award-number":["lzujbky-2018-87"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["lzujbky-2018-kb11"],"award-info":[{"award-number":["lzujbky-2018-kb11"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.lfs.2018.10.051","type":"journal-article","created":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T11:53:02Z","timestamp":1540554782000},"page":"64-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["p53 as a double-edged sword in the progression of non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"215","author":[{"given":"Zhibin","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokang","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangzhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqiu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.lfs.2018.10.051_bb0005","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.lfs.2018.10.051_bb0010","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1053\/gast.2002.36572","article-title":"AGA technical review on nonalcoholic fatty liver disease","volume":"123","author":"Sanyal","year":"2002","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.lfs.2018.10.051_bb0015","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1073\/pnas.1700172114","article-title":"Ablation of cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic steatosis and fibrosis","volume":"114","author":"Zhang","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.lfs.2018.10.051_bb0020","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jhep.2014.11.034","article-title":"Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management","volume":"62","author":"McPherson","year":"2015","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.lfs.2018.10.051_bb0025","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.1038\/s41598-018-23014-0","article-title":"Nonalcoholic fatty liver disease accelerates kidney function decline in patients with chronic kidney disease: a cohort study","volume":"8","author":"Jang","year":"2018","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.lfs.2018.10.051_bb0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.30699\/ijp.2017.25038","article-title":"Clinical manifestations and diagnosis of nonalcoholic fatty liver disease","volume":"12","author":"Khoonsari","year":"2017","journal-title":"Iran. J. Pathol."},{"issue":"3","key":"10.1016\/j.lfs.2018.10.051_bb0035","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","article-title":"Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States","volume":"148","author":"Wong","year":"2015","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.lfs.2018.10.051_bb0040","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.lfs.2018.10.051_bb0045","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jhep.2013.04.013","article-title":"Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial","volume":"59","author":"Wong","year":"2013","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.lfs.2018.10.051_bb0050","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jhep.2016.01.002","article-title":"Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease","volume":"64","author":"Luukkonen","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2018.10.051_bb0055","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1038\/ncomms5309","article-title":"TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease","volume":"5","author":"Liu","year":"2014","journal-title":"Nat. Commun."},{"issue":"6810","key":"10.1016\/j.lfs.2018.10.051_bb0060","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35042675","article-title":"Surfing the p53 network","volume":"408","author":"Vogelstein","year":"2000","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.lfs.2018.10.051_bb0065","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0955-0674(03)00038-3","article-title":"Regulation of p53 functions: let's meet at the nuclear bodies","volume":"15","author":"Gostissa","year":"2003","journal-title":"Curr. Opin. Cell Biol."},{"issue":"3","key":"10.1016\/j.lfs.2018.10.051_bb0070","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.molcel.2006.01.020","article-title":"p53 ubiquitination: Mdm2 and beyond","volume":"21","author":"Brooks","year":"2006","journal-title":"Mol. Cell"},{"issue":"Pt 24","key":"10.1016\/j.lfs.2018.10.051_bb0075","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1242\/jcs.03293","article-title":"Outcomes of p53 activation\u2014spoilt for choice","volume":"119","author":"Vousden","year":"2006","journal-title":"J. Cell Sci."},{"issue":"10","key":"10.1016\/j.lfs.2018.10.051_bb0080","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1586\/14737140.2014.948859","article-title":"Understanding p53: new insights into tumor suppression","volume":"14","author":"Kawauchi","year":"2014","journal-title":"Expert. Rev. Anticancer. Ther."},{"issue":"6381","key":"10.1016\/j.lfs.2018.10.051_bb0085","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/358015a0","article-title":"Cancer. p53, guardian of the genome","volume":"358","author":"Lane","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2018.10.051_bb0090","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cca.2014.08.015","article-title":"Mechanisms of p53 degradation","volume":"438","author":"Chao","year":"2015","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.lfs.2018.10.051_bb0095","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1096\/fj.201600845R","article-title":"Liver p53 is stabilized upon starvation and required for amino acid catabolism and gluconeogenesis","volume":"31","author":"Prokesch","year":"2017","journal-title":"FASEB J."},{"issue":"20","key":"10.1016\/j.lfs.2018.10.051_bb0100","doi-asserted-by":"crossref","first-page":"20571","DOI":"10.1074\/jbc.M400884200","article-title":"p53 involvement in the pathogenesis of fatty liver disease","volume":"279","author":"Yahagi","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.lfs.2018.10.051_bb0105","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jhep.2017.06.008","article-title":"Human germline hedgehog pathway mutations predispose to fatty liver","volume":"67","author":"Sacoto","year":"2017","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.lfs.2018.10.051_bb0110","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jhep.2012.11.042","article-title":"Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease","volume":"58","author":"Derdak","year":"2013","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.lfs.2018.10.051_bb0115","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/hep.28379","article-title":"Mutant p53 in concert with an interleukin-27 receptor alpha deficiency causes spontaneous liver inflammation, fibrosis, and steatosis in mice","volume":"63","author":"Dibra","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2018.10.051_bb0120","doi-asserted-by":"crossref","first-page":"15111","DOI":"10.1038\/ncomms15111","article-title":"Hepatic p63 regulates steatosis via IKKbeta\/ER stress","volume":"8","author":"Porteiro","year":"2017","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.lfs.2018.10.051_bb0125","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jhep.2012.05.013","article-title":"p53\/p66Shc-mediated signaling contributes to the progression of non-alcoholic steatohepatitis in humans and mice","volume":"57","author":"Tomita","year":"2012","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/j.lfs.2018.10.051_bb0130","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.tem.2012.06.007","article-title":"Regulation of lipid metabolism by p53 - fighting two villains with one sword","volume":"23","author":"Goldstein","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.lfs.2018.10.051_bb0135","article-title":"A link between TP53 polymorphisms and metabolism","volume":"3","author":"Kung","year":"2016","journal-title":"Mol. Cell. Oncol."},{"issue":"12","key":"10.1016\/j.lfs.2018.10.051_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17122074","article-title":"p53 as a regulator of lipid metabolism in cancer","volume":"17","author":"Parrales","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2018.10.051_bb0145","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/jcmm.12364","article-title":"ASPP2 attenuates triglycerides to protect against hepatocyte injury by reducing autophagy in a cell and mouse model of non-alcoholic fatty liver disease","volume":"19","author":"Xie","year":"2015","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"10.1016\/j.lfs.2018.10.051_bb0150","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jhep.2010.08.007","article-title":"Activation of p53 enhances apoptosis and insulin resistance in a rat model of alcoholic liver disease","volume":"54","author":"Derdak","year":"2011","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.lfs.2018.10.051_bb0155","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1440-1746.2009.05785.x","article-title":"Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression","volume":"24","author":"Farrell","year":"2009","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.lfs.2018.10.051_bb0160","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.celrep.2014.04.046","article-title":"Inhibition of endothelial p53 improves metabolic abnormalities related to dietary obesity","volume":"7","author":"Yokoyama","year":"2014","journal-title":"Cell Rep."},{"issue":"38","key":"10.1016\/j.lfs.2018.10.051_bb0165","doi-asserted-by":"crossref","first-page":"6198","DOI":"10.3748\/wjg.v12.i38.6198","article-title":"Expression of p53, Bax and Bcl-2 proteins in hepatocytes in non-alcoholic fatty liver disease","volume":"12","author":"Panasiuk","year":"2006","journal-title":"World J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.lfs.2018.10.051_bb0170","doi-asserted-by":"crossref","first-page":"20704","DOI":"10.3390\/ijms141020704","article-title":"Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH)","volume":"14","author":"Takaki","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.lfs.2018.10.051_bb0175","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jnutbio.2007.10.001","article-title":"The role of fatty acids in the development and progression of nonalcoholic fatty liver disease","volume":"19","author":"Gentile","year":"2008","journal-title":"J. Nutr. Biochem."},{"issue":"5","key":"10.1016\/j.lfs.2018.10.051_bb0180","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2174\/138920112799857558","article-title":"Non-alcoholic steatohepatitis: new insights from OMICS studies","volume":"13","author":"Martel","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"11","key":"10.1016\/j.lfs.2018.10.051_bb0185","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1381\/096089206778870012","article-title":"Nonalcoholic fatty liver disease of obesity","volume":"16","author":"Sachdev","year":"2006","journal-title":"Obes. Surg."},{"issue":"1","key":"10.1016\/j.lfs.2018.10.051_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbalip.2009.09.014","article-title":"Role of fatty acid uptake and fatty acid beta-oxidation in mediating insulin resistance in heart and skeletal muscle","volume":"1801","author":"Zhang","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.lfs.2018.10.051_bb0195","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s11695-010-0353-2","article-title":"Hepatic expression of adiponectin receptors increases with non-alcoholic fatty liver disease progression in morbid obesity in correlation with glutathione peroxidase 1","volume":"21","author":"Carazo","year":"2011","journal-title":"Obes. Surg."},{"issue":"3","key":"10.1016\/j.lfs.2018.10.051_bb0200","first-page":"351","article-title":"Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease","volume":"20","author":"Kohjima","year":"2007","journal-title":"Int. J. Mol. Med."},{"issue":"2","key":"10.1016\/j.lfs.2018.10.051_bb0205","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/hep.26672","article-title":"Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes","volume":"59","author":"Birkenfeld","year":"2014","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.lfs.2018.10.051_bb0210","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.3390\/ijms11041365","article-title":"Impact of dietary polyphenols on carbohydrate metabolism","volume":"11","author":"Hanhineva","year":"2010","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.lfs.2018.10.051_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076060","article-title":"Adipose weight gain during chronic insulin treatment of mice results from changes in lipid storage without affecting de novo synthesis of palmitate","volume":"8","author":"Frikke-Schmidt","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lfs.2018.10.051_bb0220","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.yjmcc.2010.09.014","article-title":"Too much or not enough of a good thing? Cardiac glucolipotoxicity versus lipoprotection","volume":"50","author":"Taegtmeyer","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3","key":"10.1016\/j.lfs.2018.10.051_bb0225","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.bbalip.2009.12.006","article-title":"Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome\u2014an allostatic perspective","volume":"1801","author":"Virtue","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"51","key":"10.1016\/j.lfs.2018.10.051_bb0230","doi-asserted-by":"crossref","first-page":"49676","DOI":"10.1074\/jbc.M208756200","article-title":"Protein kinase B\/Akt prevents fatty acid-induced apoptosis in pancreatic beta-cells (INS-1)","volume":"277","author":"Wrede","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.lfs.2018.10.051_bb0235","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.lfs.2018.10.051_bb0240","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metab. Clin. Exp."},{"issue":"27","key":"10.1016\/j.lfs.2018.10.051_bb0245","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.3748\/wjg.v24.i27.2974","article-title":"Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: from \u201ctwo hit theory\u201d to \u201cmultiple hit model\u201d","volume":"24","author":"Fang","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"6037","key":"10.1016\/j.lfs.2018.10.051_bb0250","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: old questions and new insights","volume":"332","author":"Cohen","year":"2011","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.lfs.2018.10.051_bb0255","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.2353\/ajpath.2009.080697","article-title":"Oxidative stress-mediated mitochondrial dysfunction contributes to angiotensin II-induced nonalcoholic fatty liver disease in transgenic Ren2 rats","volume":"174","author":"Wei","year":"2009","journal-title":"Am. J. Pathol."},{"issue":"11","key":"10.1016\/j.lfs.2018.10.051_bb0260","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome","volume":"2","author":"Yki-Jarvinen","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"8","key":"10.1016\/j.lfs.2018.10.051_bb0265","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1586\/17474124.2015.1056156","article-title":"Physiology and pathophysiology of liver lipid metabolism","volume":"9","author":"Ponziani","year":"2015","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2018.10.051_bb0270","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1146\/annurev.biochem.76.052305.091720","article-title":"Mitochondrial-nuclear communications","volume":"76","author":"Ryan","year":"2007","journal-title":"Annu. Rev. Biochem."},{"issue":"11","key":"10.1016\/j.lfs.2018.10.051_bb0275","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.biochi.2004.09.018","article-title":"SREBP transcription factors: master regulators of lipid homeostasis","volume":"86","author":"Eberle","year":"2004","journal-title":"Biochimie"},{"issue":"11","key":"10.1016\/j.lfs.2018.10.051_bb0280","doi-asserted-by":"crossref","first-page":"5987","DOI":"10.1073\/pnas.95.11.5987","article-title":"Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice","volume":"95","author":"Horton","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"28","key":"10.1016\/j.lfs.2018.10.051_bb0285","doi-asserted-by":"crossref","first-page":"25395","DOI":"10.1074\/jbc.M302364200","article-title":"p53 activation in adipocytes of obese mice","volume":"278","author":"Yahagi","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"Suppl. 2","key":"10.1016\/j.lfs.2018.10.051_bb0290","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1463-1326.2010.01275.x","article-title":"Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c","volume":"12","author":"Ferre","year":"2010","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.lfs.2018.10.051_bb0295","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.mce.2016.04.022","article-title":"Set7\/9, a methyltransferase, regulates the thermogenic program during brown adipocyte differentiation through the modulation of p53 acetylation","volume":"431","author":"Son","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"issue":"9","key":"10.1016\/j.lfs.2018.10.051_bb0300","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.bbadis.2014.05.009","article-title":"Apolipoprotein E receptor-2 deficiency enhances macrophage susceptibility to lipid accumulation and cell death to augment atherosclerotic plaque progression and necrosis","volume":"1842","author":"Waltmann","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.lfs.2018.10.051_bb0305","doi-asserted-by":"crossref","first-page":"28080","DOI":"10.1038\/srep28080","article-title":"Thioredoxin reductase 1 suppresses adipocyte differentiation and insulin responsiveness","volume":"6","author":"Peng","year":"2016","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.lfs.2018.10.051_bb0310","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1194\/jlr.M050658","article-title":"PPARgamma ligand production is tightly linked to clonal expansion during initiation of adipocyte differentiation","volume":"55","author":"Hallenborg","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.lfs.2018.10.051_bb0315","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.92","article-title":"Activation of PPARgamma\/P53 signaling is required for curcumin to induce hepatic stellate cell senescence","volume":"7","author":"Jin","year":"2016","journal-title":"Cell Death Dis."},{"issue":"Pt 2","key":"10.1016\/j.lfs.2018.10.051_bb0320","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1042\/bj3500599","article-title":"Characterization of rat liver malonyl-CoA decarboxylase and the study of its role in regulating fatty acid metabolism","volume":"350","author":"Dyck","year":"2000","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.lfs.2018.10.051_bb0325","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ncb2172","article-title":"p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase","volume":"13","author":"Jiang","year":"2011","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.lfs.2018.10.051_bb0330","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1158\/0008-5472.177.65.1","article-title":"Glycolytic enzymes can modulate cellular life span","volume":"65","author":"Kondoh","year":"2005","journal-title":"Cancer Res."},{"issue":"5704","key":"10.1016\/j.lfs.2018.10.051_bb0335","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1126\/science.1101731","article-title":"Nutrient availability regulates SIRT1 through a forkhead-dependent pathway","volume":"306","author":"Nemoto","year":"2004","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.lfs.2018.10.051_bb0340","doi-asserted-by":"crossref","first-page":"HY5","DOI":"10.12659\/MSM.881749","article-title":"SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease","volume":"17","author":"Colak","year":"2011","journal-title":"Med. Sci. Monit."},{"issue":"7117","key":"10.1016\/j.lfs.2018.10.051_bb0345","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature05354","article-title":"Resveratrol improves health and survival of mice on a high-calorie diet","volume":"444","author":"Baur","year":"2006","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.lfs.2018.10.051_bb0350","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1101\/gad.1987211","article-title":"Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress","volume":"25","author":"Zaugg","year":"2011","journal-title":"Genes Dev."},{"key":"10.1016\/j.lfs.2018.10.051_bb0355","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1196\/annals.1320.002","article-title":"Structure and function of carnitine acyltransferases","volume":"1033","author":"Jogl","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"28","key":"10.1016\/j.lfs.2018.10.051_bb0360","first-page":"9217","article-title":"Could metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease?","volume":"20","author":"Scalera","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2018.10.051_bb0365","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.lfs.2015.02.003","article-title":"Singular effects of PPAR agonists on nonalcoholic fatty liver disease of diet-induced obese mice","volume":"127","author":"Barbosa-da-Silva","year":"2015","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2018.10.051_bb0370","doi-asserted-by":"crossref","first-page":"34542","DOI":"10.1038\/srep34542","article-title":"p21(Cip1) plays a critical role in the physiological adaptation to fasting through activation of PPARalpha","volume":"6","author":"Lopez-Guadamillas","year":"2016","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.lfs.2018.10.051_bb0375","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/path.3001","article-title":"RXR antagonism induces G0\/G1 cell cycle arrest and ameliorates obesity by up-regulating the p53-p21(Cip1) pathway in adipocytes","volume":"226","author":"Nakatsuka","year":"2012","journal-title":"J. Pathol."},{"issue":"3","key":"10.1016\/j.lfs.2018.10.051_bb0380","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.molcel.2009.09.031","article-title":"GAMT, a p53-inducible modulator of apoptosis, is critical for the adaptive response to nutrient stress","volume":"36","author":"Ide","year":"2009","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.lfs.2018.10.051_bb0385","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/jmcb\/mjs064","article-title":"A new role of p53 in regulating lipid metabolism","volume":"5","author":"Wang","year":"2013","journal-title":"J. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.lfs.2018.10.051_bb0390","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.cmet.2006.08.005","article-title":"Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha\/PPARalpha regulatory pathway","volume":"4","author":"Finck","year":"2006","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.lfs.2018.10.051_bb0395","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.molcel.2011.08.038","article-title":"ROS-mediated p53 induction of Lpin1 regulates fatty acid oxidation in response to nutritional stress","volume":"44","author":"Assaily","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.lfs.2018.10.051_bb0400","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1146\/annurev.biochem.70.1.341","article-title":"Peroxisome proliferator-activated receptor gamma and metabolic disease","volume":"70","author":"Willson","year":"2001","journal-title":"Annu. Rev. Biochem."},{"issue":"5","key":"10.1016\/j.lfs.2018.10.051_bb0405","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1210\/jc.2010-2129","article-title":"Up-regulation of PPAR-gamma mRNA expression in the liver of obese patients: an additional reinforcing lipogenic mechanism to SREBP-1c induction","volume":"96","author":"Pettinelli","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.lfs.2018.10.051_bb0410","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064258","article-title":"Peroxisome proliferator-activated receptors-alpha and gamma are targets to treat offspring from maternal diet-induced obesity in mice","volume":"8","author":"Magliano","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.lfs.2018.10.051_bb0415","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1021\/bi991721h","article-title":"p53 regulates caveolin gene transcription, cell cholesterol, and growth by a novel mechanism","volume":"39","author":"Bist","year":"2000","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.lfs.2018.10.051_bb0420","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jhep.2011.08.022","article-title":"p53, a novel regulator of lipid metabolism pathways","volume":"56","author":"Goldstein","year":"2012","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.lfs.2018.10.051_bb0425","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.atherosclerosis.2015.02.017","article-title":"Elevated baseline plasma phospholipid protein (PLTP) levels are an independent predictor of long-term all-cause mortality in patients with diabetes mellitus and known or suspected coronary artery disease","volume":"239","author":"Cavusoglu","year":"2015","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.lfs.2018.10.051_bb0430","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/MCD.0000000000000071","article-title":"A novel mutation in the ABCA12 gene in a Turkish case of Harlequin ichthyosis","volume":"24","author":"Gurkan","year":"2015","journal-title":"Clin. Dysmorphol."},{"issue":"42","key":"10.1016\/j.lfs.2018.10.051_bb0435","doi-asserted-by":"crossref","first-page":"29097","DOI":"10.1074\/jbc.M114.574244","article-title":"Endocytosis of secreted carboxyl ester lipase in a syndrome of diabetes and pancreatic exocrine dysfunction","volume":"289","author":"Torsvik","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.lfs.2018.10.051_bb0440","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1080\/10715762.2017.1320554","article-title":"Amelioration of late-onset hepatic steatosis in IDH2-deficient mice","volume":"51","author":"Lee","year":"2017","journal-title":"Free Radic. Res."},{"issue":"23","key":"10.1016\/j.lfs.2018.10.051_bb0445","doi-asserted-by":"crossref","first-page":"E2414","DOI":"10.1073\/pnas.1315605111","article-title":"Ribosomal protein-Mdm2-p53 pathway coordinates nutrient stress with lipid metabolism by regulating MCD and promoting fatty acid oxidation","volume":"111","author":"Liu","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"30","key":"10.1016\/j.lfs.2018.10.051_bb0450","doi-asserted-by":"crossref","first-page":"21220","DOI":"10.1074\/jbc.M801824200","article-title":"Cyclin-dependent kinase inhibitor, p21WAF1\/CIP1, is involved in adipocyte differentiation and hypertrophy, linking to obesity, and insulin resistance","volume":"283","author":"Inoue","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2018.10.051_bb0455","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.mce.2015.09.004","article-title":"Molecular aspects of glucose homeostasis in skeletal muscle\u2014a focus on the molecular mechanisms of insulin resistance","volume":"417","author":"Carnagarin","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"issue":"4","key":"10.1016\/j.lfs.2018.10.051_bb0460","first-page":"419","article-title":"Glycoregulation disorders and alterations of C reactive protein in nonalcoholic fatty liver disease","volume":"44","author":"Casoinic","year":"2006","journal-title":"Rom. J. Intern. Med."},{"issue":"11","key":"10.1016\/j.lfs.2018.10.051_bb0465","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1046\/j.1440-1746.2002.02881.x","article-title":"Non-alcoholic fatty liver disease: an overview","volume":"17","author":"Mulhall","year":"2002","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2018.10.051_bb0470","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.phrs.2017.12.020","article-title":"Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: a clinical review","volume":"130","author":"Baghernya","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"9","key":"10.1016\/j.lfs.2018.10.051_bb0475","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.dld.2009.01.004","article-title":"Non-alcoholic fatty liver disease pathogenesis: the present and the future","volume":"41","author":"Petta","year":"2009","journal-title":"Dig. Liver Dis."},{"issue":"4","key":"10.1016\/j.lfs.2018.10.051_bb0480","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1159\/000375353","article-title":"Challenges and management of liver cirrhosis: practical issues in the therapy of patients with cirrhosis due to NAFLD and NASH","volume":"33","author":"Traussnigg","year":"2015","journal-title":"Dig. Dis."},{"issue":"2","key":"10.1016\/j.lfs.2018.10.051_bb0485","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.metabol.2013.09.013","article-title":"Irisin in patients with nonalcoholic fatty liver disease","volume":"63","author":"Polyzos","year":"2014","journal-title":"Metab. Clin. Exp."},{"issue":"12","key":"10.1016\/j.lfs.2018.10.051_bb0490","first-page":"13","article-title":"New metabolic index in the diagnosis of insulin resistance in patients with nonalcoholic fatty liver disease","author":"Roitberg","year":"2014","journal-title":"Exp. Clin. Gastroenterol."},{"issue":"30","key":"10.1016\/j.lfs.2018.10.051_bb0495","doi-asserted-by":"crossref","first-page":"20462","DOI":"10.1074\/jbc.R114.576355","article-title":"Pathway-selective insulin resistance and metabolic disease: the importance of nutrient flux","volume":"289","author":"Otero","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.lfs.2018.10.051_bb0500","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","article-title":"SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver","volume":"109","author":"Horton","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.lfs.2018.10.051_bb0505","first-page":"2781","article-title":"Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer","volume":"56","author":"Webster","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2018.10.051_bb0510","article-title":"Is p53 involved in tissue-specific insulin resistance formation?","volume":"2017","author":"Strycharz","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"8","key":"10.1016\/j.lfs.2018.10.051_bb0515","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/sj.onc.1205181","article-title":"Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosis","volume":"21","author":"Gottlieb","year":"2002","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.lfs.2018.10.051_bb0520","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrm1837","article-title":"Critical nodes in signalling pathways: insights into insulin action","volume":"7","author":"Taniguchi","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7","key":"10.1016\/j.lfs.2018.10.051_bb0525","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.freeradbiomed.2010.12.022","article-title":"Exercise training attenuates oxidative stress and decreases p53 protein content in skeletal muscle of type 2 diabetic Goto-Kakizaki rats","volume":"50","author":"Qi","year":"2011","journal-title":"Free Radic. Biol. Med."},{"issue":"9","key":"10.1016\/j.lfs.2018.10.051_bb0530","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/nm.2014","article-title":"A crucial role for adipose tissue p53 in the regulation of insulin resistance","volume":"15","author":"Minamino","year":"2009","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.lfs.2018.10.051_bb0535","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.molcel.2007.05.010","article-title":"Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis","volume":"26","author":"Chang","year":"2007","journal-title":"Mol. Cell"},{"issue":"6","key":"10.1016\/j.lfs.2018.10.051_bb0540","first-page":"5589","article-title":"miR-34a and miR-125b are upregulated in peripheral blood mononuclear cells from patients with type 2 diabetes mellitus","volume":"14","author":"Shen","year":"2017","journal-title":"Exp. Ther. Med."},{"issue":"10","key":"10.1016\/j.lfs.2018.10.051_bb0545","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.2174\/13894501113149990182","article-title":"miRNAs in insulin resistance and diabetes-associated pancreatic cancer: the \u2018minute and miracle\u2019 molecule moving as a monitor in the \u2018genomic galaxy\u2019","volume":"14","author":"Chakraborty","year":"2013","journal-title":"Curr. Drug Targets"},{"issue":"10","key":"10.1016\/j.lfs.2018.10.051_bb0550","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.2337\/db16-0014","article-title":"DNA damage and the activation of the p53 pathway mediate alterations in metabolic and secretory functions of adipocytes","volume":"65","author":"Vergoni","year":"2016","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.lfs.2018.10.051_bb0555","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.jhep.2009.01.021","article-title":"PPARdelta agonist attenuates alcohol-induced hepatic insulin resistance and improves liver injury and repair","volume":"50","author":"Pang","year":"2009","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.lfs.2018.10.051_bb0560","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-2001-12929","article-title":"Mitochondria in steatohepatitis","volume":"21","author":"Pessayre","year":"2001","journal-title":"Semin. Liver Dis."},{"issue":"4","key":"10.1016\/j.lfs.2018.10.051_bb0570","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/1947601911409738","article-title":"The role of p53 in metabolic regulation","volume":"2","author":"Puzio-Kuter","year":"2011","journal-title":"Genes Cancer"},{"issue":"3","key":"10.1016\/j.lfs.2018.10.051_bb0575","first-page":"316","article-title":"The role of oxidative stress in the pathogenesis of type 2 diabetes: from molecular mechanism to clinical implication","volume":"2","author":"Chang","year":"2010","journal-title":"Am. J. Transl. Res."},{"issue":"5","key":"10.1016\/j.lfs.2018.10.051_bb0580","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cmet.2012.04.001","article-title":"Inflammation and lipid signaling in the etiology of insulin resistance","volume":"15","author":"Glass","year":"2012","journal-title":"Cell Metab."},{"issue":"10","key":"10.1016\/j.lfs.2018.10.051_bb0585","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/j.celrep.2016.02.037","article-title":"The P72R polymorphism of p53 predisposes to obesity and metabolic dysfunction","volume":"14","author":"Kung","year":"2016","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.lfs.2018.10.051_bb0590","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.pharep.2016.07.010","article-title":"Animal models of insulin resistance: a review","volume":"68","author":"Sah","year":"2016","journal-title":"Pharmacol. Rep."},{"issue":"3","key":"10.1016\/j.lfs.2018.10.051_bb0595","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1530\/JOE-13-0201","article-title":"Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance","volume":"218","author":"Asrih","year":"2013","journal-title":"J. Endocrinol."},{"issue":"5","key":"10.1016\/j.lfs.2018.10.051_bb0600","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","article-title":"Mechanisms for insulin resistance: common threads and missing links","volume":"148","author":"Samuel","year":"2012","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.lfs.2018.10.051_bb0605","first-page":"205","article-title":"Relationship of non-alcoholic steatohepatitis with arterial endothelial function and atherosclerosis","volume":"22","author":"Cao","year":"2014","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"4","key":"10.1016\/j.lfs.2018.10.051_bb0610","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.cmet.2013.09.001","article-title":"Semaphorin3E-induced inflammation contributes to insulin resistance in dietary obesity","volume":"18","author":"Shimizu","year":"2013","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.lfs.2018.10.051_bb0615","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"Donath","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.lfs.2018.10.051_bb0620","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1172\/JCI34260","article-title":"Insulin sensitivity: modulation by nutrients and inflammation","volume":"118","author":"Schenk","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.lfs.2018.10.051_bb0625","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1177\/1947601911409747","article-title":"Inflammation and p53: a tale of two stresses","volume":"2","author":"Gudkov","year":"2011","journal-title":"Genes Cancer"},{"issue":"8","key":"10.1016\/j.lfs.2018.10.051_bb0630","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1096\/fj.04-3213fje","article-title":"p53 is a suppressor of inflammatory response in mice","volume":"19","author":"Komarova","year":"2005","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.lfs.2018.10.051_bb0635","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/ncb1724","article-title":"p53 regulates glucose metabolism through an IKK-NF-kappaB pathway and inhibits cell transformation","volume":"10","author":"Kawauchi","year":"2008","journal-title":"Nat. Cell Biol."},{"issue":"8","key":"10.1016\/j.lfs.2018.10.051_bb0640","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1096\/fj.09-151340","article-title":"JNK1 and IKKbeta: molecular links between obesity and metabolic dysfunction","volume":"24","author":"Solinas","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.lfs.2018.10.051_bb0645","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/637027","article-title":"Nonalcoholic fatty liver disease: pathogenesis and therapeutics from a mitochondria-centric perspective","volume":"2014","author":"Gusdon","year":"2014","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.lfs.2018.10.051_bb0650","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/hep.20755","article-title":"Oxidative mitochondrial DNA damage and deletion in hepatocytes of rejecting liver allografts in rats: role of TNF-alpha","volume":"42","author":"Nagakawa","year":"2005","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.lfs.2018.10.051_bb0655","doi-asserted-by":"crossref","first-page":"G583","DOI":"10.1152\/ajpgi.00422.2005","article-title":"Mechanisms of liver injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways","volume":"290","author":"Schwabe","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"8","key":"10.1016\/j.lfs.2018.10.051_bb0660","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1093\/carcin\/bgu134","article-title":"Caught in the cross fire: p53 in inflammation","volume":"35","author":"Cooks","year":"2014","journal-title":"Carcinogenesis"},{"issue":"5","key":"10.1016\/j.lfs.2018.10.051_bb0665","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/hep.21614","article-title":"CCAAT\/enhancing binding protein beta deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet-induced nonalcoholic steatohepatitis","volume":"45","author":"Rahman","year":"2007","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.lfs.2018.10.051_bb0670","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024307","article-title":"Sirtinol treatment reduces inflammation in human dermal microvascular endothelial cells","volume":"6","author":"Orecchia","year":"2011","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.lfs.2018.10.051_bb0675","doi-asserted-by":"crossref","first-page":"970","DOI":"10.5551\/jat.4333","article-title":"Resveratrol protects human endothelium from H(2)O(2)-induced oxidative stress and senescence via SirT1 activation","volume":"17","author":"Kao","year":"2010","journal-title":"J. Atheroscler. Thromb."},{"issue":"4","key":"10.1016\/j.lfs.2018.10.051_bb0680","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/pin.12521","article-title":"A case of primary aldosteronism caused by unilateral multiple adrenocortical micronodules presenting as muscle cramps at rest: the importance of functional histopathology for identifying a culprit lesion","volume":"67","author":"Ito","year":"2017","journal-title":"Pathol. Int."},{"issue":"6","key":"10.1016\/j.lfs.2018.10.051_bb0685","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1096\/fj.02-0774com","article-title":"Inhibition of p53 protects liver tissue against endotoxin-induced apoptotic and necrotic cell death","volume":"17","author":"Schafer","year":"2003","journal-title":"FASEB J."},{"issue":"11","key":"10.1016\/j.lfs.2018.10.051_bb0690","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026161","article-title":"p53 and the carcinogenicity of chronic inflammation","volume":"6","author":"Gudkov","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"3","key":"10.1016\/j.lfs.2018.10.051_bb0695","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.freeradbiomed.2008.04.029","article-title":"Fatty acids as modulators of the cellular production of reactive oxygen species","volume":"45","author":"Schonfeld","year":"2008","journal-title":"Free Radic. Biol. Med."},{"issue":"5","key":"10.1016\/j.lfs.2018.10.051_bb0700","doi-asserted-by":"crossref","first-page":"G1135","DOI":"10.1152\/ajpgi.2001.281.5.G1135","article-title":"Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress","volume":"281","author":"Robertson","year":"2001","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"1","key":"10.1016\/j.lfs.2018.10.051_bb0705","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2001-12927","article-title":"Etiopathogenesis of nonalcoholic steatohepatitis","volume":"21","author":"Chitturi","year":"2001","journal-title":"Semin. Liver Dis."},{"issue":"22","key":"10.1016\/j.lfs.2018.10.051_bb0710","doi-asserted-by":"crossref","first-page":"14548","DOI":"10.1073\/pnas.212319799","article-title":"Selenomethionine regulation of p53 by a ref1-dependent redox mechanism","volume":"99","author":"Seo","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.lfs.2018.10.051_bb0715","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1158\/0008-5472.CAN-2287-2","article-title":"p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis","volume":"64","author":"Hussain","year":"2004","journal-title":"Cancer Res."},{"issue":"16","key":"10.1016\/j.lfs.2018.10.051_bb0720","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.1073\/pnas.1001006107","article-title":"Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function","volume":"107","author":"Hu","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"24","key":"10.1016\/j.lfs.2018.10.051_bb0725","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.4161\/cc.22853","article-title":"Identification of NCF2\/p67phox as a novel p53 target gene","volume":"11","author":"Italiano","year":"2012","journal-title":"Cell Cycle"},{"issue":"3","key":"10.1016\/j.lfs.2018.10.051_bb0730","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cell.2008.06.028","article-title":"p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling","volume":"134","author":"Budanov","year":"2008","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.lfs.2018.10.051_bb0735","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s10038-003-0122-3","article-title":"Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses","volume":"49","author":"Yoon","year":"2004","journal-title":"J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.lfs.2018.10.051_bb0740","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1089\/15230860260196254","article-title":"Elevated oxidative stress in patients with ataxia telangiectasia","volume":"4","author":"Reichenbach","year":"2002","journal-title":"Antioxid. Redox Signal."},{"issue":"5","key":"10.1016\/j.lfs.2018.10.051_bb0745","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.cmet.2013.06.019","article-title":"Metabolic regulation by p53 family members","volume":"18","author":"Berkers","year":"2013","journal-title":"Cell Metab."},{"issue":"7334","key":"10.1016\/j.lfs.2018.10.051_bb0750","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nature09787","article-title":"Telomere dysfunction induces metabolic and mitochondrial compromise","volume":"470","author":"Sahin","year":"2011","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.lfs.2018.10.051_bb0755","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s00109-014-1223-5","article-title":"p53 in liver pathologies-taking the good with the bad","volume":"92","author":"Charni","year":"2014","journal-title":"J. Mol. Med."},{"issue":"2","key":"10.1016\/j.lfs.2018.10.051_bb0760","doi-asserted-by":"crossref","first-page":"R61","DOI":"10.1530\/JOE-16-0324","article-title":"The role of the p53 tumor suppressor in metabolism and diabetes","volume":"231","author":"Kung","year":"2016","journal-title":"J. Endocrinol."},{"issue":"27\u201328","key":"10.1016\/j.lfs.2018.10.051_bb0765","first-page":"477","article-title":"The indications for liver biopsy","volume":"109","author":"Tannapfel","year":"2012","journal-title":"Dtsch. Arztebl. Int."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320518306866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320518306866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:16:17Z","timestamp":1758399377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320518306866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":152,"alternative-id":["S0024320518306866"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2018.10.051","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"p53 as a double-edged sword in the progression of non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2018.10.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}